Screener
MiMedx Group MDXG Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $64,362 | $98,605 | $123,353 | $186,810 |
| Cost of sales | 19,981 | 18,681 | 37,348 | 35,239 |
| Gross profit | 44,381 | 79,924 | 86,005 | 151,571 |
| Operating expenses: | ||||
| Selling, general and administrative | 59,779 | 64,151 | 113,010 | 124,120 |
| Research and development | 2,777 | 3,303 | 6,917 | 6,632 |
| Amortization of intangible assets | 291 | 100 | 592 | 199 |
| Operating income | (18,466) | 12,370 | (34,514) | 20,620 |
Item 1. Financial Statements
FAQ
- What is MiMedx Group's total cost of revenue?
- MiMedx Group (MDXG) reported total cost of revenue of $19.98M in Q2 2026.
- How has MiMedx Group's total cost of revenue changed year-over-year?
- MiMedx Group's total cost of revenue increased by 7.0% year-over-year, from $18.68M to $19.98M.
- What is the long-term trend for MiMedx Group's total cost of revenue?
- Over 4 years (2021 to 2025), MiMedx Group's total cost of revenue has grown at a 14.0% compound annual growth rate (CAGR), from $43.28M to $73.01M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about MiMedx Group's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude